Max Chat
Company Analysis Biotest Aktiengesellschaft
1. Summary
Advantages
- Dividends (0.1448%) are higher than the sector average (0%).
- The stock's return over the last year (4.99%) is higher than the sector average (-2.77%).
- The company's current efficiency (ROE=5.13%) is higher than the sector average (ROE=0%)
Disadvantages
- Price (32 $) is higher than fair price (9.82 $)
- Current debt level 41.65% has increased over 5 years from 34.91%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Biotest Aktiengesellschaft | Index | ||
|---|---|---|---|
| 7 days | 0% | 0.5% | 1.6% |
| 90 days | 0% | -3.4% | 23% |
| 1 year | 5% | -2.8% | 13% |
BIESF vs Sector: Biotest Aktiengesellschaft has outperformed the "" sector by 7.76% over the past year.
BIESF vs Market: Biotest Aktiengesellschaft has significantly underperformed the market by -8.05% over the past year.
Stable price: BIESF is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BIESF with weekly volatility of 0.0959% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (32 $) is higher than the fair price (9.82 $).
Price is higher than fair: The current price (32 $) is 69.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (41.18) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (41.18) is higher than that of the market as a whole (0).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.05) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (2.05) is higher than that of the market as a whole (0).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.5) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (1.5) is higher than that of the market as a whole (0).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.09) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (13.09) is higher than that of the market as a whole (0).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -36.82% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-36.82%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (5.13%) is higher than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (5.13%) is higher than that of the market as a whole (0%).
5.5. ROA
ROA vs Sector: The company's ROA (1.86%) is higher than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (1.86%) is higher than that of the market as a whole (0%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 0.1448% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0.1448% has not been consistently paid over the past 7 years, DSI=0.64.
Weak dividend growth: The company's dividend yield 0.1448% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (6.06%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
